Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX(R) (Varenicline) Compared With Placebo

New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain abstinent during the last four weeks of treatment (weeks 9-12) compared with 8.8 percent of those given placebo (p

Related posts:

1. Is Chantix FDA Approved? Yes! Chantix was approved by FDA May 11, 2006. FDA...
2. Around One In Five Pregnant Smokers Go Undetected Each Year Self-reported smoking during pregnancy underestimates the true number of pregnant...
3. Cigarettes Seem Less Attractive To Smokers Following Exercise Exercise can help smokers quit because it makes cigarettes less...
4. Health Benefits of smoking cessation It is well documented that smoking cessation has a beneficial...
5. Quit Smoking Pill – The New way to stop smoking A quit smoking pill for smoking cessation, which works by...